{"id":4730,"date":"2019-07-18T11:19:52","date_gmt":"2019-07-18T09:19:52","guid":{"rendered":"https:\/\/irlab.se\/?p=4730"},"modified":"2022-05-13T12:10:11","modified_gmt":"2022-05-13T10:10:11","slug":"vd-intervju-med-healthcare-direkt","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/","title":{"rendered":"VD-intervju med Healthcare Direkt"},"content":{"rendered":"\n<p class=\"is-style-intro-text-style\">Healthcare Direkt intervjuar vd Nicholas Waters om de nyligen publicerade Fas 2a-resultaten med IRL790.<\/p>\n\n\n<p><iframe loading=\"lazy\" title=\"Healthcare Direkt v.29: Irlabs tolkning av fas 2a-resultaten som marknaden ratade\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/rdb22vop8lU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Videoinneh\u00e5ll<\/h3>\n\n\n\n<p><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=43s\">00:43<\/a> Beskrivning av forskningsbolaget IRLAB Therapeutics<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=60s\">01:00<\/a> IRLAB:s fas 2a studie med l\u00e4kemedelskandidaten IRL790<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=110s\">01:50<\/a> Fas 2a-studiens olika m\u00e4tmetoder av effekt<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=157s\">02:37<\/a> M\u00e4tmetoder av effekt hos andra godk\u00e4nda l\u00e4kemedel<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=225s\">03:45<\/a> M\u00f6jligheten att p\u00e5verka studieresultaten med alternativa studieutformning<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=279s\">04:39<\/a> Vikten av en god s\u00e4kerhetsprofil vid behandling av hj\u00e4rnans sjukdomar<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=368s\">06:08<\/a> N\u00e4sta steg i utvecklingen av IRL790<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=430s\">07:10<\/a> Kostnaden f\u00f6r kommande st\u00f6rre studie<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=452s\">07:32<\/a> IRLAB:s finansiering och hur l\u00e4nge de likvida medlen r\u00e4cker<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=494s\">08:14<\/a> IRLAB:s utveckling f\u00f6r aktien fr\u00e5n \u00e5rsskiftet<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=583s\">09:43<\/a> IRLAB:s vd Nicholas Waters syn p\u00e5 utfallet av studieresultaten<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=636s\">10:36<\/a> M\u00f6jligheten att anv\u00e4nda sig av m\u00e4tmetoden UDysRS-skalan i kommande studie<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=730s\">12:10<\/a> Novartis stopp av utvecklingen av CNP520 inom l\u00e4kemedelsklassen Bace-h\u00e4mmare vid behandling av Alzheimers sjukdom<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=781s\">13:01<\/a> Astra Zenecas tidigare utveckling av Bace-h\u00e4mmare<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=958s\">15:58<\/a> B\u00f6rsens kursraketer inom Life Science under 2019<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=1269s\">21:09<\/a> S\u00e4nken inom Life Science under 2019<br><a href=\"https:\/\/www.youtube.com\/watch?v=rdb22vop8lU&amp;t=1639s\">27:19<\/a> Vikten av att sprida riskerna<\/p>\n\n\n\n<p>Healthcare Direkt \u00e4r programmet d\u00e4r vi pratar om veckans h\u00e4ndelser inom life science. I veckans avsnitt g\u00e4stas vi av IRLAB:s vd Nicholas Waters som ber\u00e4ttar om deras studieresultat f\u00f6r l\u00e4kemedelskandidaten IRL790 vid behandling av ofrivilliga r\u00f6relser (dyskinesier) hos patienter med Parkinsons sjukdom i fas 2a.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Healthcare Direkt intervjuar vd Nicholas Waters om de nyligen publicerade Fas 2a-resultaten med IRL790. Videoinneh\u00e5ll 00:43 Beskrivning av forskningsbolaget IRLAB Therapeutics01:00 IRLAB:s fas 2a studie med l\u00e4kemedelskandidaten IRL79001:50 Fas 2a-studiens olika m\u00e4tmetoder av effekt02:37 M\u00e4tmetoder av effekt hos andra godk\u00e4nda l\u00e4kemedel03:45 M\u00f6jligheten att p\u00e5verka studieresultaten med alternativa studieutformning04:39 Vikten av en god s\u00e4kerhetsprofil vid behandling [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22],"tags":[],"class_list":["post-4730","post","type-post","status-publish","format-standard","hentry","category-presentationer-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>VD-intervju med Healthcare Direkt - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VD-intervju med Healthcare Direkt - IRLAB\" \/>\n<meta property=\"og:description\" content=\"Healthcare Direkt intervjuar vd Nicholas Waters om de nyligen publicerade Fas 2a-resultaten med IRL790. Videoinneh\u00e5ll 00:43 Beskrivning av forskningsbolaget IRLAB Therapeutics01:00 IRLAB:s fas 2a studie med l\u00e4kemedelskandidaten IRL79001:50 Fas 2a-studiens olika m\u00e4tmetoder av effekt02:37 M\u00e4tmetoder av effekt hos andra godk\u00e4nda l\u00e4kemedel03:45 M\u00f6jligheten att p\u00e5verka studieresultaten med alternativa studieutformning04:39 Vikten av en god s\u00e4kerhetsprofil vid behandling [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-18T09:19:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-13T10:10:11+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d\"},\"headline\":\"VD-intervju med Healthcare Direkt\",\"datePublished\":\"2019-07-18T09:19:52+00:00\",\"dateModified\":\"2022-05-13T10:10:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/\"},\"wordCount\":232,\"commentCount\":0,\"articleSection\":[\"Presentationer\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/\",\"url\":\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/\",\"name\":\"VD-intervju med Healthcare Direkt - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2019-07-18T09:19:52+00:00\",\"dateModified\":\"2022-05-13T10:10:11+00:00\",\"author\":{\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VD-intervju med Healthcare Direkt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\/\/irlab.se\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/irlab.se\/sv\/author\/irlab-user\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VD-intervju med Healthcare Direkt - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/","og_locale":"sv_SE","og_type":"article","og_title":"VD-intervju med Healthcare Direkt - IRLAB","og_description":"Healthcare Direkt intervjuar vd Nicholas Waters om de nyligen publicerade Fas 2a-resultaten med IRL790. Videoinneh\u00e5ll 00:43 Beskrivning av forskningsbolaget IRLAB Therapeutics01:00 IRLAB:s fas 2a studie med l\u00e4kemedelskandidaten IRL79001:50 Fas 2a-studiens olika m\u00e4tmetoder av effekt02:37 M\u00e4tmetoder av effekt hos andra godk\u00e4nda l\u00e4kemedel03:45 M\u00f6jligheten att p\u00e5verka studieresultaten med alternativa studieutformning04:39 Vikten av en god s\u00e4kerhetsprofil vid behandling [&hellip;]","og_url":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/","og_site_name":"IRLAB","article_published_time":"2019-07-18T09:19:52+00:00","article_modified_time":"2022-05-13T10:10:11+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"admin","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/"},"author":{"name":"admin","@id":"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d"},"headline":"VD-intervju med Healthcare Direkt","datePublished":"2019-07-18T09:19:52+00:00","dateModified":"2022-05-13T10:10:11+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/"},"wordCount":232,"commentCount":0,"articleSection":["Presentationer"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/","url":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/","name":"VD-intervju med Healthcare Direkt - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2019-07-18T09:19:52+00:00","dateModified":"2022-05-13T10:10:11+00:00","author":{"@id":"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d"},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/vd-intervju-med-healthcare-direkt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"VD-intervju med Healthcare Direkt"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Person","@id":"https:\/\/irlab.se\/#\/schema\/person\/f1a6ec2b5cf16bc3c6d2c8a3cc3b536d","name":"admin","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/irlab.se\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca9ac6d5cafa1146003fcfd4a534f2590f937c279a5018bd860f6451bcacc0a5?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/irlab.se\/sv\/author\/irlab-user\/"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/4730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=4730"}],"version-history":[{"count":3,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/4730\/revisions"}],"predecessor-version":[{"id":9442,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/4730\/revisions\/9442"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=4730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=4730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=4730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}